These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

980 related items for PubMed ID: 28260503

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High level expression and immunochemical characterization of botulinum neurotoxin type F light chain.
    Chauhan R, Chauhan V, Rao MK, Chaudhary D, Bhagyawant S, Dhaked RK.
    Protein Expr Purif; 2018 Jun; 146():51-60. PubMed ID: 29407166
    [Abstract] [Full Text] [Related]

  • 5. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.
    Mukamoto M, Maeda H, Kohda T, Nozaki C, Takahashi M, Kozaki S.
    Jpn J Infect Dis; 2013 Jun; 66(1):46-50. PubMed ID: 23429085
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y, Barash JR, Lou J, Conrad F, Marks JD, Arnon SS.
    J Infect Dis; 2016 May 15; 213(10):1606-14. PubMed ID: 26936913
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model.
    Tomic MT, Farr-Jones S, Syar ES, Niemuth N, Kobs D, Hackett MJ, Espinoza Y, Martinez Z, Pham K, Snow DM, Marks JD, Cobb RR.
    Toxins (Basel); 2021 Sep 21; 13(9):. PubMed ID: 34564675
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S, Tepp WH, Bradshaw M, Kalb SR, Dykes JK, Lin G, Nawrocki EM, Pier CL, Barr JR, Maslanka SE, Johnson EA.
    mSphere; 2016 Sep 21; 1(1):. PubMed ID: 27303710
    [Abstract] [Full Text] [Related]

  • 13. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C, Avril A, Chahboun S, Tierney R, Bak N, Miethe S, Mazuet C, Popoff MR, Thullier P, Hust M, Pelat T, Sesardic D.
    MAbs; 2015 Sep 21; 7(6):1161-77. PubMed ID: 26381852
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neutralization mechanism of human monoclonal antibodies against type B botulinum neurotoxin.
    Matsumura T, Kitamura M, Amatsu S, Yamaguchi A, Kobayashi N, Yutani M, Fujinaga Y.
    Microbiol Immunol; 2024 Oct 21; 68(10):348-358. PubMed ID: 39239735
    [Abstract] [Full Text] [Related]

  • 16. Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.
    Miethe S, Mazuet C, Liu Y, Tierney R, Rasetti-Escargueil C, Avril A, Frenzel A, Thullier P, Pelat T, Urbain R, Fontayne A, Sesardic D, Hust M, Popoff MR.
    PLoS One; 2016 Oct 21; 11(8):e0161446. PubMed ID: 27560688
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.